Send us Fan Mail

In part 3 of the MedEvidence Diabetes series Dr. Koren and Sharon Smith discuss choosing drug classes for diabetes, weight loss and cardiovascular health. 

💉GLP-1 Drug Class
💉SGLT2i Drug Class
🔬 Past and New Clinical Research Trials

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Sharon Smith, RN, CDCES is the VP of Recruitment at ENCORE Research Group, and a Diabetic Educational Nurse with a passion for educating patients as well as staff on healthy lifestyle options without giving up on special treats.

Additional podcasts on Diabetes:

• Diabetes 101
• Let’s Talk Diabetes
• A Deep Dive into Diabetes Stories & Anecdote 
• Diabetic Epidemic

Original Air Date: November 11, 2022

#demandfordata #medevidence #diabetes #medicalnews #clinincalresearch #diabeticdrugs #CGM #continuousglucosemonitor #bloodsugar 

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!